Total Funding
45
21
Total FundingPrivate Equity raised
Growth Score 45 in past quarter
-15 pts
Heat Score 21 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
139604
Azurity Pharmaceuticals is a developer of drug products and technologies to address the needs of patients.
Acquired by 
Novaquest Capital Management
- Sujeet Singh: Chief Portfolio Management OfficerPast Role: CALYPTUS PHARMACEUTICALS INC, Co-Founder and Chief Executive Officer
- Vinicius de Lima: Chief Medical OfficerPast Role: CSL Vifor, VP and Head of Global Medical Affairs
About the Company
Azurity Pharmaceuticals is a developer of drug products and technologies to address the needs of patients. Its drug products such as antimicrobial, mouthwashes, and testosterone enable pharmacists to prepare drugs for those populations who are in need of a better alternative to traditionally-compounded medications.
